PTU-067 Body Composition Profiling is a Predictor of Therapeutic Outcome in Patients with Moderate to Severe Crohn’s Disease

IntroductionAnti-tumour necrosis factor (TNF)s form a major part of therapy in Crohn’s disease and has a primary non-response rate of 10–30% and a secondary loss of response rate of 5% per patient-year. Myopenia is prevalent in patients with Crohn’s disease who are in clinical remission and can be m...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2016-06, Vol.65 (Suppl 1), p.A85-A85
Hauptverfasser:	Ding, NS, Malietzis, G, Lung, PF, Yip, WM, Penez, L, Ganeshanathan, T, Gabe, SM, Jenkins, JT, Hart, AL
Format:	Artikel
Sprache:	eng
Schlagworte:	Body composition Body fat Crohn's disease Fat-free body mass Multivariate analysis Remission Response rates Tumor necrosis factor Tumor necrosis factor-TNF Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!